Blunted vaccines responses after ocrelizumab highlight need for immunizations prior to treatment

Detalles Bibliográficos
Autores principales: Smets, I., Reyes, S., Baker, D., Giovannoni, G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier B.V. 2021
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7897403/
https://www.ncbi.nlm.nih.gov/pubmed/33636615
http://dx.doi.org/10.1016/j.msard.2021.102851
_version_ 1783653662734680064
author Smets, I.
Reyes, S.
Baker, D.
Giovannoni, G.
author_facet Smets, I.
Reyes, S.
Baker, D.
Giovannoni, G.
author_sort Smets, I.
collection PubMed
description
format Online
Article
Text
id pubmed-7897403
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Published by Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-78974032021-02-22 Blunted vaccines responses after ocrelizumab highlight need for immunizations prior to treatment Smets, I. Reyes, S. Baker, D. Giovannoni, G. Mult Scler Relat Disord Correspondence Published by Elsevier B.V. 2021-05 2021-02-21 /pmc/articles/PMC7897403/ /pubmed/33636615 http://dx.doi.org/10.1016/j.msard.2021.102851 Text en © 2021 Published by Elsevier B.V. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Correspondence
Smets, I.
Reyes, S.
Baker, D.
Giovannoni, G.
Blunted vaccines responses after ocrelizumab highlight need for immunizations prior to treatment
title Blunted vaccines responses after ocrelizumab highlight need for immunizations prior to treatment
title_full Blunted vaccines responses after ocrelizumab highlight need for immunizations prior to treatment
title_fullStr Blunted vaccines responses after ocrelizumab highlight need for immunizations prior to treatment
title_full_unstemmed Blunted vaccines responses after ocrelizumab highlight need for immunizations prior to treatment
title_short Blunted vaccines responses after ocrelizumab highlight need for immunizations prior to treatment
title_sort blunted vaccines responses after ocrelizumab highlight need for immunizations prior to treatment
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7897403/
https://www.ncbi.nlm.nih.gov/pubmed/33636615
http://dx.doi.org/10.1016/j.msard.2021.102851
work_keys_str_mv AT smetsi bluntedvaccinesresponsesafterocrelizumabhighlightneedforimmunizationspriortotreatment
AT reyess bluntedvaccinesresponsesafterocrelizumabhighlightneedforimmunizationspriortotreatment
AT bakerd bluntedvaccinesresponsesafterocrelizumabhighlightneedforimmunizationspriortotreatment
AT giovannonig bluntedvaccinesresponsesafterocrelizumabhighlightneedforimmunizationspriortotreatment

Ejemplares similares